Bayer's Innovator In Chief: Kemal Malik
This article was originally published in Scrip
Executive Summary
Dr Kemal Malik likes change. The new and novel, which coincidentally is also Malik's definition of innovation, are the momentum that keeps his role as head of innovation at Bayer AG interesting and fun.
You may also be interested in...
BIO 2016 Notebook: Pricing And Innovation Hot Topics In San Francisco
Scrip spoke with several executives and attended multiple panel discussions in San Francisco during the first full day of BIO's annual international gathering. Drug pricing and enabling innovation emerged as key themes.
Investment And Acquisition In Rare Diseases
In Vivo talks to investors, analysts and companies in rare disease about the challenges they face to innovate and to grow.
Moving The Needle In Rare Disease: UCB’s gMG Strategy
Launching a novel drug into a new market is tough. UCB’s Kimberly Moran, talked to In Vivo about how being both patient and digital first gives the company a competitive commercial advantage in an increasingly growing market.